Helena Utkovic Westergren

Helena Utkovic Westergren

Company: AstraZeneca

Job title: Precision Medicine Lead & Director


Are Markets Ready to Accept New Biomarker Developments Outside Oncology? 1:00 pm

• The increased interest in biomarker application in precision medicine beyond oncology – what does this mean to regulatory agencies and clinical guideline updates? • Planning education and awareness programmes to establish biomarkers when these aren’t normally tested for • Comparison between biomarker implementation in oncology, highlighting distinctions between planning and key learnings from established…Read more

day: Track B - Day 1 am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.